|
Risk factor | Causes/implications |
|
Sex (female) | QT intervals longer in women than in men QT interval longer during first half of menstrual cycle |
|
Age (elderly) | Comorbid coronary artery diseases Multiple medications Pharmacokinetic/pharmacodynamic changes |
|
Electrolyte imbalance Hypokalemia, hypomagnesemia Hypocalcemia | Diuretic use Excessive vomiting or diarrhea Postprandial hypokalemia |
|
Congenital long QT syndrome | Associated with torsade and sudden death |
|
Cardiac disease with history of acute or chronic myocardial ischemia, CHF, cardiac arrhythmias, and bradycardia | Increased risk of cardiac arrhythmias |
|
Drugs known to prolong QTc interval | May potentiate QTc prolongation |
|
Medication overdose with drugs that prolong the QTc interval | QTc prolongation generally dose dependent |
|
Concomitant medications, liver disease | Adverse events with cytochrome P-450 enzyme system inhibition, leading to increased drug levels that can increase QT interval |
|
Endocrine/metabolic disorders Diabetes, obesity Hypothyroidism, pituitary insufficiency | Via electrolytes or cardiovascular disease |
|
Injury to the central nervous system Stroke, infection, and trauma | Via autonomic nervous system dysfunction |
|